Research AppraisalSystematic Review

Heart rate variability as a predictor of future depressive symptoms: A systematic review and meta-analysis

Journal of affective disordersGalin, Shir, Nagy, Liliana, Turan, Caner et al.15 June 2026DOI

Clinical Snapshot

80CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationInitially non-depressed individuals from longitudinal studies
I — InterventionHeart rate variability (HRV) measurement at baseline
C — ComparatorNo specific comparator (prognostic study examining HRV as predictor)
O — OutcomesFuture depressive symptoms or internalizing symptoms at minimum one-month follow-up

Bottom Line

This comprehensive meta-analysis of 56 longitudinal studies demonstrates that lower heart rate variability predicts future depressive symptoms in initially non-depressed individuals. However, the associations are small (correlations -0.15 to -0.19), explaining only 2-4% of variance in depression outcomes. While statistically significant across multiple HRV domains, the clinical utility appears limited to adjunctive risk assessment rather than standalone screening. The context-dependent nature of effects suggests HRV may be most valuable when combined with other risk factors. For Australian clinicians, HRV could potentially enhance existing depression prevention strategies, particularly in high-risk populations, but should not replace established screening tools. The evidence supports HRV as a research tool for understanding depression vulnerability mechanisms rather than immediate clinical implementation for routine depression prediction.

Evidence: Moderate

Key Findings

  • P Value: Statistically significant for all reported HRV indices

  • Effect Size: Small negative correlations ranging from r = -0.15 to -0.19 across HRV indices

  • Primary Outcome: Correlation between baseline HRV and future depressive symptoms

  • Nnt Or Sensitivity: Effect sizes suggest limited predictive utility; correlation coefficients explain 2-4% of variance in future depression

  • Confidence Interval: 95% CIs ranging from -0.28 to -0.03 depending on HRV measure

Clinical Application

HRV measurement requires specialized equipment but is non-invasive and increasingly accessible through wearable technology Could complement existing depression screening in primary care settings; aligns with RACGP guidelines for preventive mental health approaches; no specific PBS implications as HRV is a diagnostic tool rather than treatment General population and clinical settings where depression risk assessment is relevant

Abstract

Depression has limited early detection strategies. Heart rate variability (HRV), an indicator of autonomic regulation, has been linked to depression cross-sectionally, but its prospective value remains uncertain. We performed a meta-analysis and systematic review examining whether HRV is prospectively associated with later depressive symptom levels. PubMed, Embase, Cochrane, and PsycINFO (inception November 3, 2024) were searched for longitudinal studies of initially non-depressed baseline HRV and at least one-month follow-up assessing depressive or internalizing symptoms. Meta-analyses used multilevel random-effects models; prediction models were synthesized by HRV's statistical role. From 12,023 records, 56 studies entered the meta-analysis, and 62 the qualitative synthesis. HRV showed small but significant negative correlations with later depressive symptoms for frequency-domain indices (HF-HRV (r = -0.16, 95% CI -0.22 to -0.11), LF-HRV (r = -0.19, 95% CI -0.27 to -0.10), and VLF-HRV (r = -0.19, 95% CI -0.28 to -0.11)), and time-domain indices (RMSSD (r = -0.17, 95% CI -0.28 to -0.05) and SDNN (r = -0.15, 95% CI -0.26 to -0.03)). Across prediction-models, HRV showed direct effects in 43% and conditional effects in 57%, involving RSA and nonlinear patterns. HRV reflects psychophysiological mechanisms of depression vulnerability, but its prospective effects are small and context-dependent. Clinically, HRV may function as an adjunctive tool for identifying individuals who are more vulnerable to adversity and for informing preventive strategies, including the personalization of biofeedback and other regulation-focused interventions.

References

  1. 1.Galin, S., Nagy, L., Turan, C., Laczko, D., Szabo, B., Hegyi, P., Molnár, Z., & Keri, S. (2026). Heart rate variability as a predictor of future depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 121388. https://doi.org/10.1016/j.jad.2026.121388
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service